FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
VIVIMEDLAB Share Price Discussion
Vivimed Labs Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
VIVIMEDLAB Long Term Analysts Rating
- ★★
- ★★
- ★★
- ★★
- ★★
0/5 (0 Ratings)
VIVIMEDLAB Share Price *
12.65 -0.35 (-2.69%)
* (quote may be delayed)
Find answers to all your questions on live VIVIMEDLAB message board: Is VIVIMEDLAB buy or sell? Should I buy VIVIMEDLAB shares? Why are VIVIMEDLAB shares falling? Should I invest in VIVIMEDLAB stock?
You can also check VIVIMEDLAB share price target recommended by brokerages.
VIVIMEDLAB Discussion Forum
@newsbot • Reputation: 1,933
Stocks in the news: Canara Bank, NBCC, PNB, DHFL, Shilpa Medicare, Avenue Supermarts
Vivimed Labs | Canara Bank | DHFL | Varun Beverages and Rane Holdings are stocks, which are in news today.
Vivimed Labs | Canara Bank | DHFL | Varun Beverages and Rane Holdings are stocks, which are in news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Stocks in the news: Canara Bank, NBCC, PNB, DHFL, Varun Beverages, Avenue Supermarts
Vivimed Labs | Canara Bank | DHFL | Varun Beverages and Rane Holdings are stocks, which are in news today.
Vivimed Labs | Canara Bank | DHFL | Varun Beverages and Rane Holdings are stocks, which are in news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Standalone June 2019 Net Sales at Rs 59.11 crore, down 4.64% Y-o-Y
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Consolidated June 2019 Net Sales at Rs 344.21 crore, down 4% Y-o-Y
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Standalone March 2019 Net Sales at Rs 74.60 crore, up 9.72% Y-o-Y
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Consolidated March 2019 Net Sales at Rs 348.08 crore, up 21.87% Y-o-Y
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Standalone December 2018 Net Sales at Rs 51.72 crore, down 21.51% Y-o-Y
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Consolidated December 2018 Net Sales at Rs 243.93 crore, down 18.58% Y-o-Y
Like
reply
Reply
@newsbot • Reputation: 1,933
Strides to ramp up sales in US, other regulated markets after Australia biz sale
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Standalone September 2018 Net Sales at Rs 63.50 crore, up 3.86% Y-o-Y
Like
reply
Reply
@newsbot • Reputation: 1,933
Vivimed Labs Consolidated September 2018 Net Sales at Rs 364.62 crore, Up 29.07% Y-o-Y.
Like
reply
Reply
- NewsBotSep 9 1:43 PMStocks in the news: Canara Bank, NBCC, PNB, DHFL, Shilpa Medicare, Avenue SupermartsMoneycontrolNewsBotSep 9 1:13 PMStocks in the news: Canara Bank, NBCC, PNB, DHFL, Varun Beverages, Avenue SupermartsMoneycontrolNewsBotAug 12 8:33 PMVivimed Labs Standalone June 2019 Net Sales at Rs 59.11 crore, down 4.64% Y-o-Ymoneycontrol.comNewsBotAug 12 8:33 PMVivimed Labs Consolidated June 2019 Net Sales at Rs 344.21 crore, down 4% Y-o-Ymoneycontrol.comNewsBotMay 31 10:38 PMVivimed Labs Standalone March 2019 Net Sales at Rs 74.60 crore, up 9.72% Y-o-YNewsBotMay 31 10:38 PMVivimed Labs Consolidated March 2019 Net Sales at Rs 348.08 crore, up 21.87% Y-o-YNewsBotFeb 15 9:42 PMVivimed Labs Standalone December 2018 Net Sales at Rs 51.72 crore, down 21.51% Y-o-YNewsBotFeb 15 9:37 PMVivimed Labs Consolidated December 2018 Net Sales at Rs 243.93 crore, down 18.58% Y-o-YNewsBotJan 31 1:37 AMStrides to ramp up sales in US, other regulated markets after Australia biz saleNewsBotNov 15 10:17 PMVivimed Labs Standalone September 2018 Net Sales at Rs 63.50 crore, up 3.86% Y-o-Y
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.